What is the recommended ceftriaxone (Rocephin) dosing regimen for treating neuroborreliosis (neurologic Lyme disease) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rocephin Dosing for Neurologic Lyme Disease

For adults with neurologic Lyme disease (neuroborreliosis), administer ceftriaxone 2 grams intravenously once daily for 14 days (range 10-28 days). 1

Adult Dosing Specifics

The standard regimen is straightforward:

  • Dose: 2 grams IV once daily
  • Duration: 14 days is the recommended standard, with acceptable range of 10-28 days
  • Route: Intravenous infusion over 30 minutes 2

This recommendation applies specifically to acute neurologic manifestations including:

  • Lymphocytic meningitis
  • Radiculopathy
  • Cranial neuropathies (when CNS involvement is documented)

1

Alternative Regimens

For β-lactam intolerant patients: Oral doxycycline 200-400 mg per day in 2 divided doses for 10-28 days is an acceptable alternative 1. Recent high-quality evidence from a 2021 multicenter randomized equivalence trial demonstrated that oral doxycycline 100 mg twice daily for 4 weeks was equally effective as IV ceftriaxone 2 g daily for 3 weeks 3. This is particularly relevant since doxycycline is well absorbed orally and IV administration should only rarely be needed 1.

Other parenteral alternatives include:

  • Cefotaxime 2 grams IV every 8 hours 1
  • Penicillin G 18-24 million units per day IV divided every 4 hours 1

Pediatric Dosing

For children with neurologic Lyme disease:

  • Ceftriaxone: 50-75 mg/kg IV once daily (maximum 2 grams) 1
  • For meningitis specifically: Initial dose of 100 mg/kg (not to exceed 4 grams), then 100 mg/kg/day (maximum 4 grams daily) 2
  • Duration: 14 days (range 10-28 days)
  • Infusion time: 60 minutes in neonates to reduce risk of bilirubin encephalopathy 2

For children ≥8 years: Oral doxycycline 4-8 mg/kg per day in 2 divided doses (maximum 100-200 mg per dose) is an alternative 1

Critical Administration Details

Infusion considerations:

  • Administer over 30 minutes in adults 2
  • Administer over 60 minutes in neonates 2
  • Concentrations between 10-40 mg/mL are recommended 2

Compatibility warnings from FDA labeling:

  • Do NOT use calcium-containing diluents (Ringer's solution, Hartmann's solution) - particulate formation can result 2
  • Incompatible with vancomycin, aminoglycosides, and fluconazole in admixtures 2
  • Flush IV lines thoroughly between administrations if other drugs are given 2

Duration Rationale

The 14-day standard is based on evidence showing that 10-14 days of antibiotic therapy has been associated with highly favorable outcomes in both adults and children with acute neurologic Lyme disease 1. A 2005 study comparing treatments found marked improvement with both regimens, with 79% of ceftriaxone-treated patients completely recovered at 6 months 4.

Special Populations

No dosage adjustment needed for:

  • Renal impairment (up to 2 g/day) 2
  • Hepatic impairment (up to 2 g/day) 2
  • Elderly patients (up to 2 g/day, provided no severe renal/hepatic impairment) 2

Pregnancy: Pregnant patients may be treated identically to non-pregnant patients, but avoid doxycycline 1

Clinical Pearls

  • Complete response may be delayed beyond treatment duration 1
  • Most patients respond promptly and completely to therapy 1
  • For isolated cranial nerve palsy WITHOUT meningeal signs, oral antibiotics for 14-21 days may suffice 1
  • If papilledema or sixth nerve palsy present (suggesting increased intracranial pressure), additional measures beyond antibiotics may be needed 1
  • The 2021 IDSA/AAN/ACR guidelines support these same dosing recommendations 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.